Patent · US Active

KIF5B-RET fusion molecules and uses thereof

US12239648B2 · kind B2 · utility

0Cited by
29References
26Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 4, 2022
Grant dateMar 4, 2025
Priority date—
Expiry dateApr 1, 2043

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q2600/158
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Novel RET fusion molecules and uses are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.